Palvella Therapeutics apponts Matthew Korenberg as CFO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 17 2024
0mins
New CFO Appointment: Palvella Therapeutics has appointed Matthew Korenberg as CFO, who brings over 27 years of experience in biotech and healthcare investment banking, previously serving as President and COO at Ligand Pharmaceuticals.
Merger Announcement: In July 2024, Palvella and Pieris Pharmaceuticals announced a definitive merger agreement to combine the companies in an all-stock transaction.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





